Stay updated on CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial
Sign up to get notified when there's something new on the CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial page.

Latest updates to the CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedMajor update includes a government operating status notice and a new version tag (v3.2.0); removal of a specific resource (Carcinoma of esophagus) from genetic resources.SummaryDifference3%
- Check18 days agoChange DetectedUpgrade to revision v3.1.0 with added contact details (phone and email) corresponding to support or inquiry, replacing the previous v3.0.2.SummaryDifference0.1%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; Back to Top removed.SummaryDifference0.1%
- Check40 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.2%
- Check47 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location in St. Louis, Missouri, as well as new resources related to genetic and rare diseases, specifically carcinoma of the esophagus. Additionally, several specific medical terms and substances have been added, while previous references to certain antineoplastic agents and location details have been removed.SummaryDifference2%
- Check54 days agoChange DetectedThere are no significant changes to the web page content.SummaryDifference0.1%
Stay in the know with updates to CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial page.